Loading…
Employees: 262
Size Beijing Haitian Ruisheng Science Technology (688787.SS) is a China Industrials company (Miscellaneous Commercial Services) with a market value of $1.17B, the 2015th largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥129.19 on 6 Nov 2026.
Performance Over six months the shares fell 0.7%, against -14.4% for the median peer and -16.4% for the China market (cap-weighted) — 9th highest of 21 in its peer set.
Growth Revenue grew 34.5% over the last twelve months (peer median +8.6%); the operating margin is 4.2% (peer median 9.7%).
Valuation It trades at 163.5× forward earnings against a peer median of 21.3× (most expensive of 17).
Capital Return on invested capital runs 6.9 points below its cost of capital (12.1% WACC).
Next results Next results expected around 23 Apr 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥433M | CN¥376M | CN¥236M | CN¥169M | CN¥261M |
| Revenue growth | — | +60% | +39% | -35% | — |
| Gross profit | CN¥208M | CN¥160M | CN¥137M | CN¥79.2M | CN¥161M |
| EBITDA | n/a | CN¥28.1M | CN¥18.6M | -CN¥47.7M | CN¥475,470 |
| Net income | CN¥20.4M | CN¥14.1M | CN¥11.3M | -CN¥30.4M | CN¥29.5M |
| Free cash flow | -CN¥34.2M | -CN¥26.2M | CN¥3.93M | -CN¥46.9M | -CN¥214M |
| Capital expenditure | CN¥65.6M | CN¥33.2M | CN¥31.4M | CN¥25.9M | CN¥257M |
| Total debt | CN¥10.6M | CN¥17.9M | CN¥5.03M | CN¥7.77M | CN¥0 |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 688787.SS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +60.6% | +1.3% | highest of 21 |
| 6-month return | -0.7% | -14.4% | 9th highest of 21 |
| Distance from 52-week high | -34.8% | -35.1% | 10th highest of 21 |
| Revenue growth (TTM) | +34.5% | +8.6% | 3rd highest of 21 |
| Operating margin | 4.2% | 9.7% | 8th lowest of 21 |
| Forward P/E | 163.5× | 21.3× | most expensive of 17 |
| ROIC minus cost of capital | -6.9 pp | +1.6 pp | 4th lowest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Beijing Haitian Ruisheng Science Technology 688787.SS | China | $1.17B | -1% | +34% | 4% | 163.5× | n/a | n/a |
| SBT Ultrasonic Technology 688392.SS | China | $1.16B | -19% | +42% | 17% | 52.9× | n/a | n/a |
| EMTEK (Shenzhen) 300938.SZ | China | $1.16B | -44% | +11% | 27% | 33.1× | n/a | n/a |
| Shenzhen Aoni Electronic 301189.SZ | China | $1.18B | -17% | +139% | 2% | n/a | n/a | n/a |
| China East Education 0667.HK | Hong Kong | $1.18B | -18% | +16% | 22% | 8.4× | -6.1% | +4.1% |
| Naruida Technology 688522.SS | China | $1.14B | -28% | +20% | 14% | 22.0× | n/a | n/a |
| Resolute Holdings Management RHLD | United States | $1.20B | +39% | +10% | 9% | n/a | 26.0% | n/a |
| Jadard Technology 688252.SS | China | $1.22B | -12% | +6% | 12% | 23.8× | 13.3% | +31.3% |
| Vcanbio Cell & Gene Engineering 600645.SS | China | $1.23B | -32% | -6% | 12% | 45.0× | 11.0% | +1.9% |
| FESCO 600861.SS | China | $1.11B | -18% | +4% | 1% | 10.4× | n/a | n/a |
| Shanxi Huaxiang 603112.SS | China | $1.24B | -26% | +9% | 11% | 12.1× | 1.4% | +16.2% |
| CRA International CRAI | United States | $1.24B | +42% | +11% | 10% | 22.4× | n/a | n/a |
| Prosegur Cash CASH.MC | Spain | $1.09B | +5% | -5% | 11% | 9.6× | -13.0% | +5.7% |
| BrightView BV | United States | $1.08B | -10% | +1% | 4% | 20.6× | n/a | n/a |
| Shanghai MicroPort EP Medtech 688351.SS | China | $1.27B | -23% | +20% | 3% | 135.2× | 41.7% | +26.7% |
| Bajaj Mobility BMAG.SW | Switzerland | $1.28B | +86% | -47% | -44% | 10.4× | n/a | n/a |
| Beijing Cuiwei Tower 603123.SS | China | $1.07B | -23% | -12% | -18% | n/a | n/a | n/a |
| Smartgroup SIQ.AX | Australia | $1.06B | +1% | +10% | 37% | 16.8× | -0.5% | +8.8% |
| Neurones NRO.PA | France | $1.04B | +5% | +7% | 9% | 17.1× | -8.3% | +10.3% |
| Suzhou Novoprotein Scientific 688137.SS | China | $1.33B | +161% | +8% | -62% | n/a | n/a | n/a |
| Graincorp GNC.AX | Australia | $1.02B | +9% | -2% | 0% | 46.7× | n/a | n/a |